RO128701A2 - Semi-solid pharmaceutical forms intended for topical administration, containing associations of atomized extracts of cynara scolymus, rosmarinus officinalis sp. and hyssopus officinalis sp. - Google Patents
Semi-solid pharmaceutical forms intended for topical administration, containing associations of atomized extracts of cynara scolymus, rosmarinus officinalis sp. and hyssopus officinalis sp. Download PDFInfo
- Publication number
- RO128701A2 RO128701A2 ROA201101274A RO201101274A RO128701A2 RO 128701 A2 RO128701 A2 RO 128701A2 RO A201101274 A ROA201101274 A RO A201101274A RO 201101274 A RO201101274 A RO 201101274A RO 128701 A2 RO128701 A2 RO 128701A2
- Authority
- RO
- Romania
- Prior art keywords
- officinalis
- atomized
- cynara scolymus
- extracts
- semi
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Forme farmaceutice semisolide destinate administrării locale, conținând asocieri de extracte atomizate de Cynara scolymus, Rosmarinus officinalis sp. și Hissopus officinalis sp.Semi-solid pharmaceutical forms for local administration, containing combinations of atomized extracts of Cynara scolymus, Rosmarinus officinalis sp. and Hissopus officinalis sp.
Invenția se referă la forme farmaceutice semisolide destinate administrării locale pe piele și mucoase, cu un conținut între 0.1 si 5 % asociere de extracte atomizate de Cynara scolymus, Rosmarinus officinalis sp. și Hissopus officinalis sp..The invention relates to semi-solid pharmaceutical forms for local administration to the skin and mucous membranes, with a content of between 0.1 and 5% combination of atomized extracts of Cynara scolymus, Rosmarinus officinalis sp. and Hissopus officinalis sp ..
Cerererile de brevet de invenție A/011256; 2010 și A/011257; 2010 [Andrieș AA și col] descriu forme farmaceutice semisolide, respectiv solide, conținând extracte atomizate de produse vegetale. Principiile active conținute principii active determină procese de inhibare a acțiunii metaloproteinazelor, generând după administrarea invivo un puternic efect antioxidant. Acesta este corelat cu efecte de combatere a semnelor îmbătrânirii tisulare.Patent applications A / 011256; 2010 and A / 011257; 2010 [Andrieș AA et al] describe semi-solid and solid pharmaceutical forms, containing atomized extracts of plant products. The active principles contained in the active principles determine processes of inhibition of the action of metalloproteinases, generating after the administration of invivo a powerful antioxidant effect. It is correlated with the effects of combating the signs of tissue aging.
Invenția ce face obiectul acestui dosar adaugă complexului de principii active conținutul extractului atomizat de Cynara scolymus, în cadrul unor forme farmaceutice semisolide. Considerând avantajul formelor farmaceutice semisolide hidrofile, precum și variabilitatea caracteristicilor fizico-chimice și prospectiv, a parametrilor biofarmaceutici pentru structurile moleculare care constituie amestecul complex - componente active ale extractelor, s-a urmărit dezvoltarea unor geluri de tip emulsie. Aceste vehicule bifazice prezintă potențialul de a asigura stabilitatea și biodisponibilitatea optimă a ingredientelor active. S-a optat pentru o cantitate minima de alcool etilic și poliol inferior, propilenglicolul. Acest amestec de cosolvenți a fost utilizat pentru dispersarea cantității de complex. Promotorul de absorbție a fost reprezentat fie de izopropil-miristat, fie de combinații ale acestuia cu lanolina și alcoolul oleic, ambele generând forme farmaceutice semisolide de tip emulsie.The invention that is the subject of this file adds to the complex of active principles the content of the atomized extract of Cynara scolymus, in some semi-solid pharmaceutical forms. Considering the advantage of the hydrophilic semi-solid pharmaceutical forms, as well as the variability of the physico-chemical and prospective characteristics, of the biopharmaceutical parameters for the molecular structures that constitute the complex mixture - active components of the extracts, it was followed the development of emulsion type gels. These two-phase vehicles have the potential to ensure optimum stability and bioavailability of active ingredients. The minimum amount of ethyl alcohol and lower polyol, propylene glycol was chosen. This cosolvent mixture was used to disperse the complex amount. The absorption promoter was represented by either isopropyl-myristate or its combinations with lanolin and oleic alcohol, both of which generate semi-solid pharmaceutical forms of emulsion type.
α-2 Ο 1 1 - Ο 1 2 7 4 - - 'Λ ν 2 9 *11' 2011α-2 Ο 1 1 - Ο 1 2 7 4 - - 'Λ ν 2 9 * 11' 2011
Compoziția asocierii de pulberi atomizate (Cynara scolymus : Rosmarinus officinalis : Hyssopus officinalis, 40 : 30 : 30 %), utilizate în prepararea formelor farmaceutice semisolide, a fost următoarea:The composition of the atomized powder combination (Cynara scolymus: Rosmarinus officinalis: Hyssopus officinalis, 40: 30: 30%), used in the preparation of the semi-solid pharmaceutical forms, was as follows:
Parametru ConcentrațieConcentration parameter
Acizi polifenolcarboxilici, % (g/g)Polyphenolcarboxylic acids,% (w / w)
-exprimat în acid rozmarinic4.08- expressed in rosmarinic acid4.08
-exprimat în acid cafeic3.18- expressed as caffeic acid 3.18
-exprimat în acid clorogenic3.98- expressed as chlorogenic acid3.98
Flavone, % (g/g)Flavone,% (w / w)
-exprimat în rutin4.56-expressed in routine4.56
Acid rozmarinic, mg/100g 2078.33Rosmarinic acid, mg / 100g 2078.33
Cinarina, mg/100g89.39Cinarine, mg / 100g89.39
Acid clorogenic, mg/100g 246.40Chlorogenic acid, mg / 100g 246.40
Acid cafeic, mg/100g68.34Caffeic acid, mg / 100g68.34
Luteolin 7-glicozida, mg/100g 800.77Luteolin 7-glycoside, mg / 100g 800.77
Apigenin 7-glicozida, mg/100g50.53Apigenin 7-glycoside, mg / 100g50.53
Rutin, mg/100g 305.08Routine, mg / 100g 305.08
Micro și macroelemente, mg/100gMicro and macroelements, mg / 100g
-mangan2.07-mangan2.07
-zinc1.83-zinc1.83
-magneziu-magnesium
807.50807.50
ίί
9 20119 2011
Compoziția generală a formulărilor de tip gel-emulsie este redată în continuare:The general composition of gel-emulsion formulations is shown below:
Hyssopus officinalis, 40:30:30%)Hyssopus officinalis, 40: 30: 30%)
Promotor de absorbție lipofil de tip izopropil-miristat sau combinați ale acestuia cu acizi grași și alte componente lipidice biocompatibileIsopropyl-myristate-type lipophilic absorption promoter or its combination with fatty acids and other biocompatible lipid components
Etanol absolutAbsolute ethanol
5.0 - 20.05.0 - 20.0
Apa purificată ad 100.0Purified water ad 100.0
Modul de preparareMethod of preparation
Formatorul de rețea de tip poliacrilat (de exemplu carbomer 934, 940) este hidratat, timp de 24 de ore, în 75% din cantitatea de apă prevăzută în formulă. Pentru acest sistem poliacrilic, structurarea gelului s-a realizat prin neutralizare cu trietanol-amina.The polyacrylate network former (for example carbomer 934, 940) is hydrated, for 24 hours, in 75% of the amount of water provided in the formula. For this polyacrylic system, the gel was structured by neutralization with triethanol-amine.
Gelurile rezultate sunt neutralizate, prin adăugare agentului de neutralizare.The resulting gels are neutralized by adding the neutralizing agent.
Asocierea de pulberi atomizate se dizolvă sau se dispersează în amestecul de propilenglicol și etanol, în care a fost dispersat anterior promotorul de absorbție lipofil.The association of atomized powders is dissolved or dispersed in the mixture of propylene glycol and ethanol, in which the lipophilic absorption promoter was previously dispersed.
Gelul neutralizat si sistemul micelar conținând componentele pulberilor din asociere se reunesc și se omogenizează prin agitare lentă.The neutralized gel and the micellar system containing the components of the powders in the association are combined and homogenized by slow agitation.
ÎX-2 Ο 1 1 - Ο 1 2 7 4 - 2 9 -11- 2011ÎX-2 Ο 1 1 - Ο 1 2 7 4 - 2 9 -11- 2011
Apa purificată până laPurified water up to
100100
Exemplul 2Example 2
^- 2 0 1 1 - 0 1 2 7 4-- '7^ - 2 0 1 1 - 0 1 2 7 4-- '7
9 -11- 20119-11-11, 2011
Exemplul 3Example 3
ComponentComponent
Cantitate (g/1OOg)Quantity (g / 1OOg)
Asociere de pulberi atomizate (Cynara scolymus : Rosmarinus officinalis : 1Association of atomized powders (Cynara scolymus: Rosmarinus officinalis: 1
Hyssopus officinalis, 40:30:30%)Hyssopus officinalis, 40: 30: 30%)
Carbomer 940Carbomer 940
0.50.5
Trietanolamină ad pH 7Triethanolamine at pH 7
Propilenglicolpropylene
Izopropil-miristatIsopropyl-myristate
Etanol absolutAbsolute ethanol
Apa purificată până laPurified water up to
100100
Exemplul 4Example 4
Apa purificată până laPurified water up to
100100
t\- 2 O 1 1 - O 1 2 7 4 - - .7t \ - 2 O 1 1 - O 1 2 7 4 - - .7
9 -11- 20119-11-11, 2011
Exemplul 5Example 5
Hyssopus officinalis, 40:30:30%)Hyssopus officinalis, 40: 30: 30%)
Carbomer 940Carbomer 940
Trietanolamină ad pH 7Triethanolamine at pH 7
Propilenglicolpropylene
Izopropil-miristatIsopropyl-myristate
Etanol absolutAbsolute ethanol
Apa purificată până laPurified water up to
100100
Apa purificată până laPurified water up to
100100
Exemplul 7 (χ- 2 Ο 1 1 - Ο 1 2Example 7 (χ- 2 Ο 1 1 - Ο 1 2
9 -11- 2Π119 -11- 2Π11
Carbomer 940Carbomer 940
Trietanolamină ad pH 7Triethanolamine at pH 7
Propilenglicolpropylene
Izopropil-miristatIsopropyl-myristate
Etanol absolutAbsolute ethanol
Apa purificată până laPurified water up to
100100
Exemplul 8Example 8
Hyssopus officinalis, 40:30:30%)Hyssopus officinalis, 40: 30: 30%)
Etanol absolutAbsolute ethanol
Apa purificată până laPurified water up to
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ROA201101274A RO128701A2 (en) | 2011-11-29 | 2011-11-29 | Semi-solid pharmaceutical forms intended for topical administration, containing associations of atomized extracts of cynara scolymus, rosmarinus officinalis sp. and hyssopus officinalis sp. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ROA201101274A RO128701A2 (en) | 2011-11-29 | 2011-11-29 | Semi-solid pharmaceutical forms intended for topical administration, containing associations of atomized extracts of cynara scolymus, rosmarinus officinalis sp. and hyssopus officinalis sp. |
Publications (1)
Publication Number | Publication Date |
---|---|
RO128701A2 true RO128701A2 (en) | 2013-08-30 |
Family
ID=49030019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ROA201101274A RO128701A2 (en) | 2011-11-29 | 2011-11-29 | Semi-solid pharmaceutical forms intended for topical administration, containing associations of atomized extracts of cynara scolymus, rosmarinus officinalis sp. and hyssopus officinalis sp. |
Country Status (1)
Country | Link |
---|---|
RO (1) | RO128701A2 (en) |
-
2011
- 2011-11-29 RO ROA201101274A patent/RO128701A2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5798745B2 (en) | Topically applied cosmetic or pharmaceutical composition | |
US8173145B2 (en) | Formulation containing phosphate derivatives of electron transfer agents | |
AU2008229604A1 (en) | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof | |
JP6352560B2 (en) | External composition containing ascorbic acid and / or salt thereof | |
JP6231624B2 (en) | Method for producing nanoliposomes for cosmetics in which oleanolic acid is collected | |
JP5102944B2 (en) | Topical skin preparation | |
KR102558185B1 (en) | Cosmetic composition containing pseudo-ceramide originated from botanical oil | |
JP2005263794A (en) | Collagen synthesis acceleration composition | |
US6521662B2 (en) | Ceramide-like compounds having antioxidant property and a method for preparation thereof, and a cosmetic composition containing the same | |
JP2005047910A (en) | Sebum secretion-inhibiting composition | |
ES2804029T3 (en) | Composition containing polyunsaturated fatty acid | |
RU2643928C2 (en) | Medical and cosmetic means for external application | |
JP4637441B2 (en) | Skin composition containing ascorbic acid | |
EP3283055A1 (en) | Natural-substance combination containing at least one glycyrrhetinic acid and at least one guggelsterone and use thereof for cosmetic applications | |
RO128701A2 (en) | Semi-solid pharmaceutical forms intended for topical administration, containing associations of atomized extracts of cynara scolymus, rosmarinus officinalis sp. and hyssopus officinalis sp. | |
JP2003063996A (en) | Skin care preparation | |
KR101208120B1 (en) | Vitamin complex, preparation methods and cosmetic composition comprising thereof | |
JP5856761B2 (en) | External preparation for skin and method for producing the same | |
KR101716426B1 (en) | Skin external composition for alleviating itch comprising vernixcaseosamimetic lipid complex and arctium lappa seed extracts | |
KR20200131795A (en) | Composition for stabilizing insoluble ingredient and cosmetic composition containing the same | |
JP2006248953A (en) | Wrinkle ameliorating agent and external composition for skin | |
KR101655256B1 (en) | Skin external composition for alleviating itch comprising ginsenoside rg3 | |
RU2553347C1 (en) | Hair care product | |
JP3140513B2 (en) | External pharmaceutical base and external pharmaceutical composition | |
JP5671211B2 (en) | External preparation for skin containing hydroxycarboxylic acid derivative |